These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 35326462
1. Vogt-Koyanagi-Harada Disease Exacerbation Associated with COVID-19 Vaccine. De Domingo B, López M, Lopez-Valladares M, Ortegon-Aguilar E, Sopeña-Perez-Argüelles B, Gonzalez F. Cells; 2022 Mar 16; 11(6):. PubMed ID: 35326462 [Abstract] [Full Text] [Related]
2. Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease. Vukojević M, Vukojevic N, Vuković A, Rupčić B, Blažević M, Blažević A. Acta Dermatovenerol Croat; 2023 Dec 16; 31(4):229-231. PubMed ID: 38651852 [Abstract] [Full Text] [Related]
3. De Novo Vogt-Koyanagi-Harada Disease following Covid-19 Vaccine: A Case Report and Literature Overview. Brunet de Courssou JB, Tisseyre M, Hadjadj J, Chouchana L, Broca F, Terrier B, Duraffour P, Henriquez S. Ocul Immunol Inflamm; 2022 Jul 16; 30(5):1292-1295. PubMed ID: 35113742 [Abstract] [Full Text] [Related]
4. Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine. Koong LR, Chee WK, Toh ZH, Ng XL, Agrawal R, Ho SL. Ocul Immunol Inflamm; 2021 Aug 18; 29(6):1212-1215. PubMed ID: 34505819 [Abstract] [Full Text] [Related]
5. Vogt-Koyanagi-Harada Disease following mRNA-1273 (Moderna) COVID-19 Vaccination. Joo CW, Kim YK, Park SP. Ocul Immunol Inflamm; 2022 Jul 18; 30(5):1250-1254. PubMed ID: 35404752 [Abstract] [Full Text] [Related]
6. A COVID-19 perspective of Vogt-Koyanagi-Harada disease. Dutta Majumder P, Sadhu S, González-López JJ, Mochizuki M. Indian J Ophthalmol; 2023 Jun 18; 71(6):2587-2591. PubMed ID: 37322685 [Abstract] [Full Text] [Related]
7. Case report: Bilateral panuveitis resembling Vogt-Koyanagi-Harada disease after second dose of BNT162b2 mRNA COVID-19 vaccine. Sato T, Nihei R, Sora D, Nishio Y, Takeuchi M. Front Immunol; 2022 Jun 18; 13():967972. PubMed ID: 36248859 [Abstract] [Full Text] [Related]
8. Vogt-Koyanagi-Harada Relapse after COVID-19 Vaccination. Accorinti M, Saturno MC, Manni P. Ocul Immunol Inflamm; 2022 Jul 18; 30(5):1228-1233. PubMed ID: 35201950 [Abstract] [Full Text] [Related]
9. Vogt-Koyanagi-Harada disease following ChAdOx1 nCoV-19 and mRNA-1273 vaccination. Rujkorakarn P, Patamatamkul S. J Fr Ophtalmol; 2023 Mar 18; 46(3):207-210. PubMed ID: 36775731 [Abstract] [Full Text] [Related]
10. COVID-19 Developed During Systemic Steroid Therapy for Vogt-Koyanagi-Harada Disease: A Case Report. Niidome S, Usui Y, Tsubota K, Sugawara R, Goto H. Ocul Immunol Inflamm; 2023 Aug 18; 31(6):1305-1309. PubMed ID: 37084286 [Abstract] [Full Text] [Related]
11. Clinical features, diagnosis, and management of COVID-19 vaccine-associated Vogt-Koyanagi-Harada disease. Xu K, Gao B, Li J, Xiang Y, Cao L, Zhao M. Hum Vaccin Immunother; 2023 Aug 01; 19(2):2220630. PubMed ID: 37282614 [Abstract] [Full Text] [Related]
15. [Vitiligo revealing Vogt -Koyanagi-Harada disease]. Amraoui ME, Zemmez Y, Bouhamidi A, Frikh R, Hjira N, Boui M. Pan Afr Med J; 2017 Aug 01; 27():220. PubMed ID: 28979622 [Abstract] [Full Text] [Related]